Co Q10 enzyme with Omega 3,6,9

We are committed to maintaining the exceedingly highest standard in selected therapeutic segments in non-communicable diseases, specialising in the cardiovascular disease whereby helping patients to achieve optimal health.

Cardiovascular Diaseases

Recent studies show that the Co Q10 supplement can signicantly increase HDL-C and ApoA1 levels, even if in people taking statins, and may help reduce risk for CVD . Co Q10 supplementation also lowers the levels of inflammatory biomarkers shown to be risk factors for CVD, such as high-sensitivity C-reactive protein. Finally, low Q10 levels have ebben assorciated with greater tissue damage to the heart during heart attack and brain during stroke

Statin - Related Muscle Symptoms

Although statin therapy can significantly reduce heart attack and stroke risk, upto 25 percent of patients quit treatment within six months due to side effects, such as muscle aches and weakness. In a 2014 randomized clinical study published in Medical Science Monitor, 75 percent of statin users with muscle symptoms reported reduced pain after taking CoQ10 twice a day for 30 days, versus zero improvement in the placebo group. The researchers concluded that combining statin therapy with CoQ10 supplements could lead to higher compliance with treatment.

Heart Failure (HF)

Co Q10 was hailed as "the first drug to improve heart failure mortality in over and decade" after a multi-center randomized study of 420 patients found that taking it reduced deaths in patients with severe HF by half, compared to control group. The researchers tracked the patients for two years.(The study was presented at the Heart Failure 2013 congree in Lisbon and later published in Journal of the American College of Cardiology Heart Failure)

After a Heart Attack

In a randomized clinical trial, patients who received Co Q10 soon after a heart attack had much lower rate of subsequent cardiac events over the next year than a control group (24.6 percent versus 45 percent). About half the patients in both groups were also taking a statin medication, prompting the researchers to report that, "treatment with Co Q10 in patients with recent (heart attack) maybe beneficial in patients with high risk of atherothrombosis, despite optimal lipid lowering therapy.


In an analysis of 12 clinical studies, researches reported that Co Q10 has the potential to lower systolic lood presuure (the top number in a blood pressure reading) by up to 17mmHg and diastolic by 10mmHg without significant side effects.